As part of our monthly news service we would like to make you aware of the CML publications of the month. From the many papers published every month Professor Timothy Hughes has selected topical, interesting papers for your perusal that also include interesting publications on pediatric CML and from the LMICs.

Read Professor Hughes' CML publications of the month: July 2025

Clinical CML papers

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
  Apperley JF et al. Leukemia, July 2025 (epub ahead of publication) 
  – open access publication
• Improving chronic myeloid leukemia management and quality of life:
  Patient and physician survey of unmet needs from the CML SUN Study
  Lang F et al. Haematologica, July 2025 (epub ahead of publication)  – open access publication
• Management of chronic myeloid leukemia in 2025 - Review
  Kantarjian H et al. Cancer, July 2025 - open access publication
• Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus
  Giai V et al. Cancer, July 2025 – open access publication
• Advancing quality of life in chronic myeloid leukemia: Where do we stand?
  Lipton JH. Haematologica, July 2025 (epub ahead of print)
• Potential therapeutic targets in chronic myeloid leukemia - Review
  Bansal M and Varma M. Med Oncol, July 2025
• How will genomic testing impact a clinician’s choice for managing chronic myeloid leukemia?
  Sia J and Shanmunagathan N. Expert Rev Hematol, July 2025 (epub ahead of print)
• Secondary malignancies after chronic myeloid leukemia upon TKI treatment: Population trends and outcomes
  Zu Y et al. Br J Haematol, July 2025 (epub ahead of print) – open access publication
• Gene expression analysis of patients with chronic myeloid leukemia who discontinued tyrosine kinase inhibitors
  Park H et al. Ann Hematol, July 2025 (epub ahead of print) – open access publication
• The incidence of vascular adverse events and usefulness of novel risk assessment tool of Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
  Watanabe et al. Cardiooncology, July 2025 – open access publication
• Reconstructing CML guidelines for first line treatment from two different points of view
  Gambacorti-Passerini C et al. Blood Cancer J, July 2025 – open access publication

Scientific CML papers

• Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1
  Shi Y et al. Blood, July 2025 (epub ahead of print)

Pediatric CML papers

• Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia
  Krizkova J et al. Leukemia, July 2025 – open access publication
• Long-term endocrine outcomes and quality of life in pediatric and young chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: A prospective study from India
  Mohan R et al. Front Oncol, July 2025 – open access publication

LMIC papers

• Introducing diagnostic testing for chronic myeloid leukemia in a public hospital setting in Western Kenya
  Orido M et al. Arch Pathol Lab Med, July 2025 – open access publication
• Budget impact analysis of treatment-free remission in chronic myeloid leukemia patients treated with nilotinib in Tunisia
  Hizem A et al. J Cancer Policy, July 2025 (epub ahead of print)